Wellington Management Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62.3M | Buy |
248,636
+232,776
| +1,468% | +$57.9M | 0.01% | 663 |
|
|
2025
Q4 | $4.36M | Buy |
15,860
+1,241
| +8% | +$339K | ﹤0.01% | 1438 |
|
|
2025
Q3 | $3.84M | Buy |
14,619
+813
| +6% | +$198K | ﹤0.01% | 1500 |
|
|
2025
Q2 | $3.02M | Buy |
13,806
+312
| +2% | +$66.7K | ﹤0.01% | 1489 |
|
|
2025
Q1 | $3.02M | Buy |
13,494
+6,838
| +103% | +$1.88M | ﹤0.01% | 1472 |
|
|
2024
Q4 | $2.18M | Buy |
6,656
+99
| +2% | +$31.2K | ﹤0.01% | 1549 |
|
|
2024
Q3 | $1.97M | Buy |
6,557
+799
| +14% | +$245K | ﹤0.01% | 1543 |
|
|
2024
Q2 | $1.9M | Buy |
5,758
+337
| +6% | +$119K | ﹤0.01% | 1527 |
|
|
2024
Q1 | $2.15M | Sell |
5,421
-416
| -7% | -$154K | ﹤0.01% | 1507 |
|
|
2023
Q4 | $2.06M | Buy |
5,837
+2,201
| +61% | +$779K | ﹤0.01% | 1491 |
|
|
2023
Q3 | $1.36M | Sell |
3,636
-310
| -8% | -$120K | ﹤0.01% | 1548 |
|
|
2023
Q2 | $1.51M | Buy |
3,946
+429
| +12% | +$153K | ﹤0.01% | 1527 |
|
|
2023
Q1 | $1.22M | Sell |
3,517
-28
| -0.8% | -$8.18K | ﹤0.01% | 1605 |
|
|
2022
Q4 | $834K | Buy |
3,545
+195
| +6% | +$46.2K | ﹤0.01% | 1680 |
|
|
2022
Q3 | $825K | Sell |
3,350
-2,285
| -41% | -$696K | ﹤0.01% | 1694 |
|
|
2022
Q2 | $1.7M | Buy |
5,635
+2,063
| +58% | +$671K | ﹤0.01% | 1569 |
|
|
2022
Q1 | $1.47M | Sell |
3,572
-2,462
| -41% | -$964K | ﹤0.01% | 1663 |
|
|
2021
Q4 | $2.83M | Buy |
6,034
+2,063
| +52% | +$888K | ﹤0.01% | 1595 |
|
|
2021
Q3 | $1.69M | Sell |
3,971
-2,967
| -43% | -$1.25M | ﹤0.01% | 1708 |
|
|
2021
Q2 | $2.49M | Sell |
6,938
-1,388
| -17% | -$459K | ﹤0.01% | 1635 |
|
|
2021
Q1 | $2.35M | Sell |
8,326
-2,656
| -24% | -$760K | ﹤0.01% | 1598 |
|
|
2020
Q4 | $3.11M | Buy |
10,982
+5,089
| +86% | +$1.43M | ﹤0.01% | 1400 |
|
|
2020
Q3 | $1.62M | Sell |
5,893
-4,969
| -46% | -$1.31M | ﹤0.01% | 1451 |
|
|
2020
Q2 | $2.47M | Buy |
10,862
+3,706
| +52% | +$728K | ﹤0.01% | 1320 |
|
|
2020
Q1 | $1.09M | Buy |
+7,156
| New | +$1.1M | ﹤0.01% | 1509 |
|
|
2019
Q2 | – | Sell |
-19,599
| Closed | -$2.16M | – | 2138 |
|
|
2019
Q1 | $2.16M | Buy |
+19,599
| New | +$2.04M | ﹤0.01% | 1602 |
|
|
2018
Q4 | – | Sell |
-10,255
| Closed | -$1.27M | – | 2222 |
|
|
2018
Q3 | $1.27M | Sell |
10,255
-3,678
| -26% | -$412K | ﹤0.01% | 1823 |
|
|
2018
Q2 | $1.38M | Buy |
13,933
+796
| +6% | +$73.3K | ﹤0.01% | 1815 |
|
|
2018
Q1 | $1.16M | Buy |
13,137
+3,494
| +36% | +$327K | ﹤0.01% | 1870 |
|
|
2017
Q4 | $952K | Buy |
9,643
+2,089
| +28% | +$205K | ﹤0.01% | 1919 |
|
|
2017
Q3 | $728K | Buy |
+7,554
| New | +$684K | ﹤0.01% | 1968 |
|
|
2014
Q3 | – | Sell |
-29,600
| Closed | -$1.25M | – | 2249 |
|
|
2014
Q2 | $1.25M | Hold |
29,600
| – | – | ﹤0.01% | 1778 |
|
|
2014
Q1 | $1.3M | Buy |
+29,600
| New | +$1.39M | ﹤0.01% | 1774 |
|
Other funds holding WST
VCM
VPM
GIM
Wellington Management Group's WST Position: Q1 2026 in Review
Wellington Management Group increased its West Pharmaceutical (WST) stake by 1,468% in Q1 2026, buying an estimated $57.9M and bringing the position to 248,636 shares worth $62.3M. The position accounts for 0.01% of the portfolio, ranked #663.
Wellington Management Group first reported a position in WST in Q1 2014 and has held it in 33 quarters since. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Wellington Management Group held 248,636 shares of West Pharmaceutical worth $62.3M as of Q1 2026.
- Wellington Management Group bought 232,776 West Pharmaceutical shares in Q1 2026, an estimated $57.9M.
- West Pharmaceutical made up 0.01% of Wellington Management Group's portfolio in Q1 2026, its #663 holding.
- Wellington Management Group first reported a position in West Pharmaceutical in Q1 2014 and has held it in 33 quarters since.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.